Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-02-01 @ 3:52 PM
Study NCT ID:
NCT00804934
Status:
COMPLETED
Last Update Posted:
2012-05-28
First Post:
2008-12-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
Sponsor:
Organization:
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: